Introduction
Movement disorders (MD) are complex neurological conditions affecting the amount and fluidity of available movement and movement control. These conditions have multiple possible causes and do not fit into other established diagnostic categories. MD, which include conditions such as Parkinson's disease (PD), multiple system atrophy (MSA), progressive supranuclear palsy (PSP), corticobasal syndrome, cervical dystonia and others, have a significant impact on the quality of life of individuals worldwide but the prevalence and incidence rates vary by condition and geographical area (Abbas et al., 2018).
The prevalence of MD increase with age (Wenning et al., 2005), with essential tremor and PD being more common (Luo et al., 2025; Song et al., 2021). The spectrum of movement impairments is very broad, with bradykinesia or hypokinesia at one end of the spectrum and tremor, dystonia, chorea, stereotypies, athetosis, myoclonus and other dyskinesias at the other end of the spectrum (Jankovic and Lang, 2021). In hyperkinetic disorders, the abnormal involuntary movements may occur at rest or during voluntary movements and may be rhythmic (e.g., tremor), sustained (e.g., dystonia) or irregular (e.g., chorea and myoclonus) (Arabia et al., 2022; Novellino et al., 2009; Perju-Dumbrava and Kempster, 2020; Stephen et al., 2023). On the other hand, hypokinetic disorders are characterized by a reduction in voluntary movements and/or difficulty in initiating movements (Jankovic and Lang, 2021). MD often have no identifiable cause and are referred to as primary MD, as opposed to secondary MD, which have identifiable causes, such as infection (Desai et al., 2024; Divya et al., 2024). Both groups present with both motor and non-motor symptoms are present, and the diagnosis and management of these conditions is a challenging task for healthcare professionals, especially knowing that diagnostic criteria frameworks are diverse (Mestre et al., 2023).
For a complete assessment, historical—family and personal, including birth history and early developmental abnormalities—and clinical features obtained during the physical examination and laboratory testing are of paramount importance (Jankovic and Lang, 2021). In addition, technology—such as apps and wearables—has shown promising results in increasing the objectivity of the assessment (Caroppo et al., 2025; Vanmechelen et al., 2023; Willemse et al., 2024) but proper validation studies are needed to increase the confidence of clinicians in implementing these solutions in clinical practice.
The management of people with MD is also challenging, as they often experience difficulties with mobility, balance and activities of daily living, and non-motor symptoms, such as cognitive changes and psychiatric symptoms also manifest as the condition progresses. Given the progressive nature of these conditions, a palliative approach can help throughout the clinical course of the complex and long-term symptoms (Miyasaki et al., 2022). Pharmacological therapy is a cornerstone in the management of MD (Jankovic, 2009; Pirker et al., 2023) but other approaches, such as gene therapy (e.g. Kim and Chang, 2024), are becoming increasingly relevant. Moreover, increasing evidence highlights the therapeutic potential of non-pharmacological approaches such as exercise therapy, and nutrition-based interventions, to reduce the progression and severity of motor and non-motor symptoms (Ferrazzoli et al., 2022; Lister, 2020; Macías-García et al., 2024; Zhang et al., 2024).
The aim of this Research Topic was to share ideas, approaches, opinions, and comments on the latest research providing evidence on the mechanisms and safety of exercise- and diet-induced changes (e.g. neuroprotective, anti-inflammatory and immunological) and strategies to improve adherence and empowerment of people with MD in different contexts, as these are gaps that still need to be filled with high quality evidence.
This Research Topic includes eight papers that address these questions. Four of these are original research papers and four are literature reviews that deepen our understanding of these interventions and their practical applications. Among the original research contributions, Mateus and Castro Caldas reported on three cases of supranuclear palsy, describing the benefits of physiotherapy through exercise in improving functionality and quality of life; a cross-sectional study strengthened the knowledge on the association between motor function and health-related quality of life in people with PD (Ge et al.), providing insights on which aspects should be tackled by healthcare professionals; Yaqoob et al. have demonstrated that an accelerometer-based assessment of gait and sit-to-stand tasks in people with cervical dystonia has good agreement with direct observation; and Toloraia et al. presented a non-randomized study demonstrating the benefits of a multimodal (exercise, speech and cognitive) training programme in improving motor and cognitive function in people with PD.
The systematic reviews published in this Research Topic have provided valuable insights into the quality and the certainty of the existing evidence that can guide clinicians working with people with MD, as well as gaps that may guide future research in this area. Homann et al. showed that the existing randomized controlled trials analyzing the benefits of Vitamin D supplementation in later life show a potential benefit on a very limited number of MD. However, the very limited number of trials mainly led the authors to conclude that there is a clear need for further clinical research in this area. For exercise interventions, the evidence is more robust and three systematic reviews provide valuable insights for both clinicians and researchers. Yuan et al. presented a network meta-analysis identifying specific exercise modalities and dosages that significantly improve functionality in patients with PD, with aquatic exercise emerging as the most effective modality. These findings are partially challenged by Liu et al., who concluded that hydrotherapy had a positive maintenance effect on balance function in this population, but no significant long-term effects on motor function, mobility, and quality of life. Finally, Cui et al. highlighted the importance of adherence to the ACSM recommendations when prescribing exercise to patients with PD, as interventions with higher compliance to recommendations were more beneficial in improving motor function, balance, mobility, and quality of life in this population.
Taking into account the contributions to this Research Topic, the body of evidence on exercise and diet interventions in MD has been strengthened. However, there is less evidence on dietary interventions.
Conclusion
As the prevalence of MD is expected to increase, research into the management of these conditions is needed. Diet and exercise interventions are key components of a multidisciplinary rehabilitation strategy for people with MD, but research is lacking, particularly on dietary interventions. This Research Topic contributes to the growing body of evidence supporting exercise and dietary interventions for MD. We hope that these findings will inspire further research and inform clinical practice to improve the quality of life of people affected by these challenging conditions.
Statements
Author contributions
AS: Writing – original draft, Writing – review & editing. CS: Writing – review & editing. MB-F: Writing – review & editing. RT: Writing – review & editing. DC: Writing – review & editing.
Acknowledgments
We extend our gratitude to the authors, reviewers, and editorial team for their invaluable contributions to this Research Topic.
Conflict of interest
The authors declare the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
Abbas M. M. Xu Z. Tan L. C. (2018). Epidemiology of Parkinson's disease—East versus West. Mov. Disord. Clin. Pract. 5, 14–28. 10.1002/mdc3.12568
2
Arabia G. De Martino A. Moro E. (2022). Sex and gender differences in movement disorders: Parkinson's disease, essential tremor, dystonia and chorea. Int. Rev. Neurobiol.164, 101–128. 10.1016/bs.irn.2022.06.010
3
Caroppo A. Manni A. Rescio G. Carluccio A. M. Siciliano P. A. Leone A. et al . (2025). Movement disorders and smart wrist devices: a comprehensive study. Sensors25:266. 10.3390/s25010266
4
Desai S. Ibrahim N. M. Garg D. Yadav R. Iacono D. Ugawa Y. et al . (2024). Definition, diagnosis and classification of infection-related movement disorders: Consensus proposal. Parkinsonism Relat. Disord. 124:106988. 10.1016/j.parkreldis.2024.106988
5
Divya K. Cherian A. Paramasivan N. K. Krishna S. Amod R. Sundaram S. et al . (2024). Increased occurrence of functional movement disorders during the COVID-19 pandemic. Ann. Mov. Disord.7, 88–93. 10.4103/aomd.aomd_46_23
6
Ferrazzoli D. Ortelli P. Iansek R. Volpe D. (2022). Rehabilitation in movement disorders: from basic mechanisms to clinical strategies. Handb. Clin. Neurol.184, 341–355. 10.1016/B978-0-12-819410-2.00019-9
7
Jankovic J. (2009). Treatment of hyperkinetic movement disorders. Lancet Neurol.8:844856. 10.1016/S1474-4422(09)70183-8
8
Jankovic J. Lang A. E. (2021). “Diagnosis and assessment of Parkinson disease and other movement disorders,” in Bradley's Neurology in Clinical Practice, 8th Edn, eds. R. B. Daroff, J. Jankovic, J. C. Mazziotta, and S. L. Pomeroy (Amsterdam: Elsevier), 310–333.
9
Kim J. Chang M.-Y. (2024). Gene therapy for Parkinson's disease using midbrain developmental genes to regulate dopaminergic neuronal maintenance. Int. J. Mol. Sci.25:12369. 10.3390/ijms252212369
10
Lister T. (2020). Nutrition and lifestyle interventions for managing Parkinson's disease: a narrative review. J. Mov. Disord.13:97. 10.14802/jmd.20006
11
Luo Y. Qiao L. Li M. Wen X. Zhang W. Li X. et al . (2025). Global, regional, national epidemiology and trends of Parkinson's disease from 1990 to 2021: findings from the Global Burden of Disease Study 2021. Front. Aging Neurosci.16:1498756. 10.3389/fnagi.2024.1498756
12
Macías-García D. Méndez-Del Barrio M. Canal-Rivero M. Muñoz-Delgado L. Adarmes-Gómez A. Jesús S. et al . (2024). Combined physiotherapy and cognitive behavioral therapy for functional movement disorders: a randomized clinical trial. JAMA Neurol.81, 966–976. 10.1001/jamaneurol.2024.2393
13
Mestre T. A. Fabbri M. Luo S. Stebbins G. T. Goetz C. G. Sampaio C. et al . (2023). A unified framework for evidence-based diagnostic criteria programs in movement disorders. Mov. Disord.38, 1156–1162. 10.1002/mds.29420
14
Miyasaki J. M. Lim S. Y. Chaudhuri K. R. Antonini A. Piemonte M. Richfield E. et al . (2022). Access and attitudes toward palliative care among movement disorders clinicians. Mov. Disord.37, 182–189. 10.1002/mds.28773
15
Novellino F. Arabia G. Bagnato A. Cascini G. L. Salsone M. Nicoletti G. et al . (2009). Combined use of DAT-SPECT and cardiac MIBG scintigraphy in mixed tremors. Mov. Disord.24:2242–2248. 10.1002/mds.22771
16
Perju-Dumbrava L. Kempster P. (2020). Movement disorders in psychiatric patients. BMJ Neurol. Open2:e000057. 10.1136/bmjno-2020-000057
17
Pirker W. Katzenschlager R. Hallett M. Poewe W. (2023). Pharmacological treatment of tremor in Parkinson's disease revisited. J. Parkinsons Dis.13, 127–144. 10.3233/JPD-225060
18
Song P. Zhang Y. Zha M. Yang Q. Ye X. Yi Q. et al . (2021). The global prevalence of essential tremor, with emphasis on age and sex: a meta-analysis. J. Glob. Health11:04028. 10.7189/jogh.11.04028
19
Stephen C. D. Simonyan K. Ozelius L. Breakefield X. O. Sharma N. (2023). “Dystonia,” in Neurobiology of Brain Disorders, eds. M. J. Zigmond, C. A. Wiley, and M.-F. Chesselet (San Diego, CA: Academic Press), 713–751. 10.1016/B978-0-323-85654-6.00003-4
20
Vanmechelen I. Haberfehlner H. De Vleeschhauwer J. Van Wonterghem E. Feys H. Desloovere E. (2023). Assessment of movement disorders using wearable sensors during upper limb tasks: a scoping review. Front. Robot. AI9:1068413. 10.3389/frobt.2022.1068413
21
Wenning G. K. Kiechl S. Seppi K. Müller J. Högl B. Saletu M. et al . (2005). Prevalence of movement disorders in men and women aged 50–89 years (Bruneck Study cohort): a population-based study. Lancet Neurol.4, 815–820. 10.1016/S1474-4422(05)70226-X
22
Willemse I. H. Schootemeijer S. van den Bergh R. Dawes H. Nonnekes J. H. van de Warrenburg B. P. et al . (2024). Smartphone applications for movement disorders: towards collaboration and re-use. Parkinsonism Relat. Disord.120:105988. 10.1016/j.parkreldis.2023.105988
23
Zhang Y. Liu S. Xu K. Zhou Y. Shen Y. Liu Z. et al . (2024). Non-pharmacological therapies for treating non-motor symptoms in patients with Parkinson's disease: a systematic review and meta-analysis. Front. Aging Neurosci.16:1363115. 10.3389/fnagi.2024.1363115
Summary
Keywords
exercise, physical activity, diet, movement disorders, disability, quality of life, functionality
Citation
Seixas A, Silva C, Bernardo-Filho M, Taiar R and Caputo DdCdS (2025) Editorial: Effectiveness of exercise and diet on movement disorders. Front. Aging Neurosci. 17:1571000. doi: 10.3389/fnagi.2025.1571000
Received
04 February 2025
Accepted
10 February 2025
Published
20 February 2025
Volume
17 - 2025
Edited and reviewed by
Robert Petersen, Central Michigan University, United States
Updates
Copyright
© 2025 Seixas, Silva, Bernardo-Filho, Taiar and Caputo.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Adérito Seixas aderito@ufp.edu.pt
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.